Prior authorization documentation should make a clinical coverage decision understandable to the next person who reads the case — another pharmacist, a medical director, an auditor, an appeals reviewer, a prescriber, or a member-service representative. Good documentation shows what was requested, which criteria applied, what evidence was available, and why the request was approved, denied, pended, or escalated. The core formula: decision + applicable criterion + supporting evidence + next action.
The goal is not to write the longest note. The goal is to leave a clean clinical trail.
This guide provides fictional examples for pharmacist training. Always use the member's actual benefit, current policy, employer procedures, approved templates, and legally required notices.
Why Prior Authorization Documentation Matters
Prior authorization is a utilization-management process used to determine whether a medication request satisfies the conditions for coverage under a pharmacy benefit. Managed-care pharmacists may evaluate clinical need, treatment history, dosing, safety, and formulary requirements.
For Medicare Part D, a coverage determination can include decisions about prior authorization, step therapy, and quantity or dose limits. Formal notices, deadlines, exception requests, and appeal rights are governed by applicable CMS requirements and the plan's approved process.3
An internal pharmacist note does not replace a required member notice. The operational system and approved notice language control.
The Four Questions Every Note Should Answer
1. What was requested? Medication, strength, dosage form, directions, quantity, days' supply, diagnosis, new start or continuation, and patient age/weight when relevant.
2. Which criterion controls the decision? Do not write only “criteria not met.” Identify the criterion: “The policy requires documented failure, intolerance, or contraindication to two preferred preventive medication classes.”
3. What evidence was submitted? State what the record does or does not establish: “Topiramate was used for three months and stopped because of cognitive adverse effects. No second qualifying preventive trial or contraindication was documented.”
4. What happens next? Depending on the workflow: approve, deny, pend or request additional information, approve a covered quantity and deny the excess, escalate for medical-director review, route to an exception or appeal process, request dose clarification, or review under a different policy pathway.
A Simple Documentation Framework
Use REQUEST-CRITERIA-EVIDENCE-DECISION-NEXT STEP: what exactly is being reviewed, which policy requirement applies, what facts support or fail to support the criterion, the decision (approve/deny/pend/partially approve/escalate), and what information or process is available next.
Approval Documentation Examples
Approval language should establish why the request qualifies. It should not merely say that the request was approved.
General approval: “The requested medication meets the applicable coverage criteria. The submitted records document the qualifying diagnosis, required previous therapy, and a requested dose within the policy limit.”
Approval after step therapy: “The request meets criteria based on documented trial and inadequate response to the required preferred therapies. Medication A was used from [date] to [date] with [outcome], and Medication B was used from [date] to [date] with [outcome]. The requested dose and quantity are within policy limits.”
Approval with a contraindication bypass: “The preferred-treatment requirement is bypassed because the submitted records document [contraindication or clinically significant intolerance], which is recognized by the policy. The remaining diagnosis, age, dose, and quantity criteria are met.”
Continuation approval: “Continuation criteria are met. Since starting treatment, the record documents [measurable clinical response], with ongoing tolerability and a requested dose within the reauthorization limit.”
Appeal overturn approval: “The appeal is approved based on new clinical information not available during the initial review. The submitted [specialist note, laboratory result, treatment history, or adverse-reaction documentation] establishes the previously unmet criterion.”
Denial Documentation Examples
A denial should identify the exact criterion not met and the evidence supporting that conclusion. Avoid language that blames the prescriber or patient.
Missing previous therapy: “The requested medication does not meet the applicable coverage criteria because the required previous treatment history has not been documented. The submitted records do not establish the medication name, dose, treatment duration, and outcome for the required preferred therapy.”
Insufficient number of trials: “The policy requires failure, intolerance, or contraindication to two qualifying therapies. The records document one qualifying trial of [Medication A]. A second qualifying trial, intolerance, or contraindication was not submitted.”
Quantity-limit denial: “The clinical criteria are met; however, the requested quantity exceeds the plan limit of [covered quantity] per [time period]. The request is for [requested quantity], and documentation supporting a quantity-limit exception was not provided.”
Continuation response not documented: “The continuation request does not meet the reauthorization requirement because the submitted records do not document the required clinical response. The note states [general statement], but does not include [required measurable outcome].”
Duplicate therapy: “The request does not meet the concurrent-therapy requirement. The available claims or medication history show active use of [Medication A], and the submitted treatment plan does not document discontinuation before starting [Medication B].”
Pend or Additional-Information Examples
A pend should ask for information that could change the decision. It should not request an entire chart when one precise item is missing.
Missing treatment details: “Additional information is required to determine whether the previous-treatment criterion is met. Please provide the medication name, dose, approximate treatment dates, duration, and clinical outcome for [therapy or class].”
New start versus continuation: “Please clarify whether this is a new-start or continuation request. The submission is marked continuation, but the clinical note states that treatment is planned and no recent claim or administration history is available.”
Dose clarification: “Please confirm the intended dose, frequency, and quantity. The prescription directions and requested quantity do not produce the same days' supply.”
Escalation Documentation Examples
Escalation language should identify the unresolved issue and why it exceeds routine pharmacist authority.
Clinical ambiguity: “The case has been escalated for additional clinical review because the policy language does not clearly address [specific issue], and the available facts could support more than one interpretation.”
Safety concern: “The request has been escalated because the submitted regimen raises a potential safety concern involving [dose, interaction, duplicate therapy, organ function, pregnancy, age, or another factor] that requires review beyond the routine coverage pathway.”
Urgent request with missing evidence: “The expedited request is approaching the applicable turnaround deadline, and the required [laboratory value or clinical record] remains unavailable or unreadable. Outreach attempts and the missing information have been documented, and the case has been escalated according to the urgent-review procedure.”
Step-Therapy Documentation Examples
Step-therapy documentation should distinguish between no trial, inadequate duration, inadequate response, intolerance, contraindication, successful trial, and a historical medication with insufficient detail.
Adequate failure: “[Medication] was used at [dose] from approximately [date] to [date]. The record documents persistent [symptoms or objective outcome] despite treatment, supporting inadequate response.”
Insufficient historical listing: “[Medication] appears on the historical medication list; however, the record does not establish the dose, duration, treatment outcome, intolerance, or contraindication. The listing alone does not confirm an adequate trial.”
Quantity and Days' Supply Documentation
Quantity reviews should show the arithmetic.
Quantity exceeds limit: “At the prescribed directions of [directions], the requested quantity of [quantity] provides approximately [days' supply]. The policy limit is [covered quantity] per [time period].”
Loading and maintenance doses: “The request includes a loading regimen of [regimen] followed by maintenance dosing of [regimen]. The loading and maintenance quantities were evaluated separately under the applicable limits.”
New-Start and Continuation Examples
New-start denial: “The request is being reviewed as a new start because the submitted note states that treatment is planned and no current treatment history is documented. The new-start requirement for [criterion] has not been met.”
Objective improvement (reauthorization): “Reauthorization criteria are met. The record documents improvement from [baseline] to [current value], representing [percentage or absolute change], with continued treatment tolerance.”
Vague response: “The statement that the patient is ‘stable’ or ‘doing well’ does not establish the required response measure of [criterion]. Baseline and current values are needed.”
Appeal Documentation Examples
Uphold denial: “The initial denial is upheld. The appeal materials do not include new information establishing the unmet criterion of [criterion]. The submitted documentation continues to show [supporting fact].”
Overturn denial: “The initial denial is overturned because the appeal includes new documentation of [trial, contraindication, diagnosis, laboratory result, or response], which satisfies the previously unmet criterion.”
Professional Tone: What to Avoid
Avoid: “The doctor failed to provide the required information.” Use: “The submitted records do not include the required information.”
Avoid: “The patient never tried the preferred drug.” Use: “A qualifying trial, intolerance, or contraindication to the preferred drug was not documented.”
Avoid: “Denied because the patient does not qualify.” Use: “The request does not meet the following coverage criterion: [criterion].”
Avoid: “More notes needed.” Use: “Please provide [specific item] to determine whether [specific criterion] is met.”
Common Documentation Mistakes
1. Copying criteria without applying them — a note should connect criteria to case facts. 2. Adding facts not in the record — don't convert possibilities into documentation. 3. Using an old template without checking the current request. 4. Writing vague denials — “criteria not met” is not enough. 5. Requesting unnecessary information. 6. Ignoring dose and quantity when the diagnosis criteria are otherwise met. 7. Mixing internal notes with formal notice language — a phrase bank is not a substitute for approved regulatory notices. 8. Including unnecessary protected health information — never paste member information into unapproved external tools.
A Final Quality Check
Before submitting, verify: correct member and request; correct medication and formulation; correct diagnosis pathway; new start or continuation; age and weight; previous therapy; dose, directions, quantity, and days' supply; exact unmet or satisfied criterion; evidence matches the record; decision matches the rationale; appropriate next action; approved template and notice requirements; and no unnecessary or unsupported statements.
Final Takeaway
Strong prior authorization documentation is concise because the reasoning is organized, not because the case is oversimplified. A reliable note says what was requested, what the policy requires, what the record shows, what decision follows, and what happens next. That structure turns a clinical decision into a trail another reviewer can follow without needing a lantern and a map.
PA Documentation Phrase Bank & Determination Builder
Ready-to-adapt language for every scenario in this guide, plus an interactive tool that generates an editable draft from de-identified case facts.
Get the Free Phrase Bank →Ready to build a draft? Try the interactive DocTayo PA Determination Builder — select a decision type and category, enter de-identified case facts, and generate an editable training draft.
Frequently Asked Questions
What's the difference between a denial note and a required member notice?
An internal pharmacist note documents clinical reasoning for the case file. A required member notice follows the plan's approved template and applicable regulatory language, including appeal rights and deadlines. One does not substitute for the other.
How much detail should a pend request include?
Ask for the smallest set of information that could resolve the outstanding criterion — not an entire chart. A precise, specific request is easier for the prescriber's office to fulfill quickly.
Is a medication list entry enough to prove a treatment trial?
No. A medication appearing on a historical list does not establish an adequate trial by itself — the record needs to document dose, duration, and outcome.
Why does professional tone matter in denial language?
Denial language that blames the prescriber or patient invites more pushback and complicates peer-to-peer conversations. Factual, neutral, record-focused language documents the same decision without creating unnecessary friction.
A reliable note says what was requested, what the policy requires, what the record shows, what decision follows, and what happens next. That structure is a trail another reviewer can follow.
References
- Academy of Managed Care Pharmacy (AMCP). Prior Authorization. amcp.org/concepts-managed-care-pharmacy/prior-authorization
- Academy of Managed Care Pharmacy (AMCP). Formulary and Utilization Management. amcp.org/resources-news/formulary-utilization-management
- Centers for Medicare & Medicaid Services (CMS). Medicare Prescription Drug Appeals and Grievances. cms.gov/medicare/appeals-grievances/prescription-drug
METHUVIA AI — Pharmacist-Guided Prior Authorization
I'm building an AI-assisted PA adjudication platform where the engine surfaces recommendations, but a licensed pharmacist makes every final coverage decision — not the other way around.
See what I'm building →